MedTrace Logo

Case Series With Saneso 360° Gastroscope

NCT04621591 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-11-10

No results posted yet for this study

Summary

To confirm the procedural performance of the Saneso 360° gastroscope in Esophago-gastro-duodenoscopy (EGD) procedures.

Conditions

  • EGD Procedure

Interventions

DEVICE

Saneso 360° gastroscope

Subjects will have a clinically indicated per standard of care routine EGD procedure performed with the Saneso 360° gastroscope.

Sponsors & Collaborators

  • West Virginia University

    collaborator OTHER

  • Saneso Inc.

    lead INDUSTRY

Principal Investigators

  • George Goetz, M.D; Ph.D. · West Virginia School of Medicine, Morgantown, WV

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-08-30
Completion
2020-09-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04621591 on ClinicalTrials.gov